MARKET

ONC

ONC

BeOne Medicines Ltd.
NASDAQ
310.75
-1.37
-0.44%
After Hours: 310.75 0 0.00% 18:25 05/11 EDT
OPEN
317.20
PREV CLOSE
312.12
HIGH
318.00
LOW
309.15
VOLUME
346.71K
TURNOVER
--
52 WEEK HIGH
385.22
52 WEEK LOW
218.31
MARKET CAP
34.53B
P/E (TTM)
69.56
1D
5D
1M
3M
1Y
5Y
1D
BeOne Medicines Ltd (6160) Gets a Buy from CMBC International
TipRanks · 18h ago
BeOne Medicines (ONC) Is Up 7.4% After Guidance Hike And Priority Review Win In HER2 Cancer
Simply Wall St · 19h ago
UBS Reaffirms Their Buy Rating on BeOne Medicines Ltd (6160)
TipRanks · 2d ago
CMB International Securities Remains a Buy on BeOne Medicines Ltd (6160)
TipRanks · 2d ago
Morgan Stanley Reaffirms Their Buy Rating on BeOne Medicines Ltd (6160)
TipRanks · 2d ago
BeOne Medicines Ltd (6160) Gets a Buy from CLSA
TipRanks · 2d ago
Citi Remains a Buy on BeOne Medicines Ltd (6160)
TipRanks · 2d ago
UOB Kay Hian Sticks to Their Buy Rating for BeOne Medicines Ltd (6160)
TipRanks · 2d ago
More
About ONC
BeOne Medicines AG, formerly BeiGene, Ltd., is a global oncology company engaged in discovering and developing treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, the Company is engaged in the development of its diverse pipeline of novel therapeutics. Its products include Brukinsa, Tevimbra and Pamiparib. Brukinsa is an orally available, small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Tevimbra is a humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is designed to minimize binding to Fc-gamma (Fcy) receptors on macrophages, helping the body’s immune cells detect and fight tumors. The Company’s product pipeline in development includes Sonrotoclax, Tarlatamab, Zanidatamab, Blinatumomab, BGB-26808, BGB-R046, BG-68501, BG-C9074, BGB-43395, Xaluritamig, and others.

Webull offers BeOne Medicines AG (ADR) stock information, including NASDAQ: ONC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONC stock methods without spending real money on the virtual paper trading platform.